May 23, 2019 / 6:46 AM / 3 months ago

UPDATE 1-Slovenian drugmaker Krka Q1 profit jumps by 42% as sales rise

(Updates with details, quote)

LJUBLJANA, May 23 (Reuters) - Slovenian generic drugs producer Krka made a group net profit of 70.3 million euros ($78.4 million) in the first quarter of 2019 versus 49.4 million euros in the same period last year, Krka said in a statement on Thursday.

It said sales rose to 378.5 million euros, up from 338 million a year ago.

Sales in Eastern Europe, Krka’s largest market, rose by 15%, while sales in Western Europe were 14% higher.

Krka also confirmed its goals for 2019, which were originally revealed in November, according to which profit is expected to reach at least 172 million euros - on a par with last year’s level.

Sales are seen rising to 1.4 billion euros from 1.3 billion last year.

“The management will strive to exceed these goals,” the company said in a statement, giving no further details.

Krka is Slovenia’s largest listed company with a market capitalisation of 1.9 billion euros.

$1 = 0.8969 euros Reporting by Marja Novak; Editing by Mark Potter

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below